Figure 1From: Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trialsMaR as measured by CESSFP vs T2w using only datasets diagnostic by both methods (143/212) and grouped by vendor.Back to article page